CoChat

Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model

Open access
Zhou, Qihui, Mareljic, Nikola, Michaelsen, Meike, Parhizkar, Samira, Heindl, Steffanie, Nuscher, Brigitte, Farny, Daniel, Czuppa, Mareike, Schludi, Carina, Graf, Alexander, Krebs, Stefan, Blum, Helmut, Feederle, Regina, Roth, Stefan, Haass, Christian, Arzberger, Thomas, Liesz, Arthur, Edbauer, Dieter · 2020 · EMBO Molecular Medicine
Cited by 64

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

The C9orf72 repeat expansion is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD). Non‐canonical translation of the expanded repeat results in abundant poly‐GA inclusion pathology throughout the CNS. (GA) 149 ‐CFP expression in mice triggers motor deficits and neuroinflammation. Since poly‐GA is transmitted between cells, we investigated the therapeutic potential of anti‐GA antibodies by vaccinating (GA) 149 ‐CFP mice. To overcome poor immunogenicity, we compared the antibody response of multivalent ovalbumin‐(GA) 10 conjugates and pre‐aggregated carrier‐free (GA) 15 . Only ovalbumin‐(GA) 10 immunization induced a strong anti‐GA response. The resulting antisera detected poly‐GA aggregates in cell culture and patient tissue. Ovalbumin‐(GA) 10 immunization largely rescued the motor function in (GA) 149 ‐CFP transgenic mice and reduced poly‐GA inclusions. Transcriptome analysis showed less neuroinflammation in ovalbumin‐(GA) 10 ‐immunized poly‐GA mice, which was corroborated by semiquantitative and morphological analysis of microglia/macrophages. Moreover, cytoplasmic TDP‐43 mislocalization and levels of the neurofilament light chain in the CSF were reduced, suggesting neuroaxonal damage is reduced. Our data suggest that immunotherapy may be a viable primary prevention strategy for ALS/FTD in C9orf72 mutation carriers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.201910919

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 64

Metadata

Authors
Zhou, Q., Mareljic, N., Michaelsen, M., Parhizkar, S., Heindl, S., Nuscher, B., Farny, D., Czuppa, M., Schludi, C., Graf, A., Krebs, S., Blum, H., Feederle, R., Roth, S., Haass, C., Arzberger, T., Liesz, A., & Edbauer, D.
Venue
EMBO Molecular Medicine
Published
2019-12-20
Volume
12
Issue
2
Pages
e10919-e10919
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2995882197
Cited by
64
References
25
FWCI
4.86
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. https://app.cochat.ai/papers/10.15252/emmm.201910919
The paper
Zhou, Q., Mareljic, N., Michaelsen, M., Parhizkar, S., Heindl, S., Nuscher, B., Farny, D., Czuppa, M., Schludi, C., Graf, A., Krebs, S., Blum, H., Feederle, R., Roth, S., Haass, C., Arzberger, T., Liesz, A., & Edbauer, D. (2020). Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201910919

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.